Copyright: ©Author(s) 2026.
World J Clin Oncol. Apr 24, 2026; 17(4): 118070
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.118070
Published online Apr 24, 2026. doi: 10.5306/wjco.v17.i4.118070
Figure 3 A 64-year-old woman treated using drug-eluting bead transarterial chemoembolization in the oxaliplatin group.
A: Chest computed tomography revealed a malignant tumour in the right lung (asterisk), associated with obstructive atelectasis; B: Pathology demonstrated squamous cell carcinoma; C: The right bronchial artery was the blood-supplying artery of the tumour and was embolised using oxaliplatin-eluting beads; D: The right intercostal artery was also embolised; E: The lung tumour (asterisk) was found to shrink at the 1-month follow-up; F: The tumour (asterisk) showed stable disease after 55 months, and the patient died of tumour progression after 88 months.
- Citation: Yuan HF, Kuang DL, Jiao DC, Bi YH. Three kinds of drug-eluting bead transarterial chemoembolisation for treating patients with unresectable non-small cell lung cancer. World J Clin Oncol 2026; 17(4): 118070
- URL: https://www.wjgnet.com/2218-4333/full/v17/i4/118070.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i4.118070